Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$1.9 - $4.3 $60,591 - $137,127
31,890 Added 3.79%
873,090 $2.9 Million
Q1 2023

May 15, 2023

BUY
$1.89 - $2.93 $916,593 - $1.42 Million
484,970 Added 136.14%
841,200 $1.79 Million
Q4 2022

Feb 14, 2023

BUY
$2.48 - $3.43 $883,450 - $1.22 Million
356,230 New
356,230 $958,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $406M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Hotchkis & Wiley Capital Management LLC Portfolio

Follow Hotchkis & Wiley Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hotchkis & Wiley Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hotchkis & Wiley Capital Management LLC with notifications on news.